NCT07074912

Brief Summary

The study aims to evaluate whether unscheduled return visits within one week for similar complaints are impacted by ensuring parents leave the emergency department (ED) with a prescription for appropriately dosed acetaminophen and ibuprofen for their child.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
440

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 1, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

July 20, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
Last Updated

July 20, 2025

Status Verified

July 1, 2025

Enrollment Period

1 year

First QC Date

July 1, 2025

Last Update Submit

July 10, 2025

Conditions

Keywords

emergency departmentfeverpediatrics

Outcome Measures

Primary Outcomes (1)

  • Unscheduled return visits

    The primary outcome will be unscheduled revisits to the emergency department or urgent care (binary endpoint, i.e., yes/no). This information will be obtained directly from the caregiver/parent of the child. One week (7 days) after the initial visit to the emergency department, research personnel will call the parent/caregiver to ask about length of symptoms and any unscheduled return visits to the emergency department or urgent care for the same symptoms. Any return visits to an emergency department or urgent care will be noted as yes. Well child visits will not be counted.

    7 days

Secondary Outcomes (1)

  • Parental satisfaction

    7 days

Study Arms (2)

Prescription for weight-based dosing of antipyretic

EXPERIMENTAL

The intervention group (n=220) will receive prescription with weight-based dosing for acetaminophen (also known and prescribed as Tylenol) and ibuprofen (also known and prescribed as Motrin).

Other: Prescription for weight-based dosing of antipyretic

Standard discharge instructions

ACTIVE COMPARATOR

The control group (n=220) will also receive standardized printed discharge instructions, which includes the appropriate dose of acetaminophen (also known as Tylenol) and ibuprofen (also known as Motrin) but no prescription.

Other: Standard discharge instructions

Interventions

The intervention group (n=220) will receive prescription with weight-based dosing for acetaminophen (also prescribed and known as Tylenol) and ibuprofen (also prescribed and known as Motrin).

Prescription for weight-based dosing of antipyretic

The control group (n=220) will also receive standardized printed discharge instructions but no prescription. The discharge instructions include the appropriate dose of acetaminophen (also known as Tylenol) and ibuprofen (also known as Motrin).

Standard discharge instructions

Eligibility Criteria

Age6 Months - 36 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children 6 to \< 36 months of age being discharged home from Dell Children's Medical Center emergency department who are evaluated for fever
  • Caregiver fluent in English or Spanish

You may not qualify if:

  • Previous enrollment in this study
  • Patient admitted to hospital
  • Parental request for a prescription for acetaminophen and/or ibuprofen
  • Trauma patient
  • Orthopedic complaint
  • Other painful indication for acetaminophen or ibuprofen
  • Acetaminophen or ibuprofen prescribed for anything other than fever
  • Allergy or another contraindication to acetaminophen or ibuprofen
  • Parent and patient unlikely to follow up in the region (i.e., lives out of state)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dell Children's Medical Center

Austin, Texas, 78723, United States

RECRUITING

Related Publications (2)

  • Section on Clinical Pharmacology and Therapeutics; Committee on Drugs; Sullivan JE, Farrar HC. Fever and antipyretic use in children. Pediatrics. 2011 Mar;127(3):580-7. doi: 10.1542/peds.2010-3852. Epub 2011 Feb 28.

    PMID: 21357332BACKGROUND
  • Trapani S, Fiordelisi A, Stinco M, Resti M. Update on Fever of Unknown Origin in Children: Focus on Etiologies and Clinical Approach. Children (Basel). 2023 Dec 24;11(1):20. doi: 10.3390/children11010020.

    PMID: 38255334BACKGROUND

MeSH Terms

Conditions

FeverEmergencies

Interventions

Prescriptions

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Intervention Hierarchy (Ancestors)

Pharmaceutical ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Matthew Wilkinson, MD, MPH

    The University of Texas at Austin

    STUDY DIRECTOR

Central Study Contacts

Lina Palomares, RN, LMSW

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Project Manager

Study Record Dates

First Submitted

July 1, 2025

First Posted

July 20, 2025

Study Start

December 15, 2024

Primary Completion

December 31, 2025

Study Completion

March 15, 2026

Last Updated

July 20, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

IDP will not be shared to protect patient confidentiality.

Locations